[EN] PIPERIDINE-2, 6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF<br/>[FR] DÉRIVÉS DE PIPÉRIDINE-2, 6-DIONE QUI SE LIENT AU CÉRÉBLON, ET PROCÉDÉS D'UTILISATION DE CEUX-CI
申请人:CAPTOR THERAPEUTICS S A
公开号:WO2021105335A1
公开(公告)日:2021-06-03
The present invention provides novel compounds which bind to cereblon, and methods of use thereof. The compounds are represented by Formulas (Ia), (Ib), (IIa) and (IIb), below: Formula (Ia), Formula (Ib), Formula (IIa), Formual (IIb).
A photochromic material having a ring opening quantum yield of 10
−3
or lower which does not fade under ambient light is provided. The material comprises a compound belonging to the diheteroarylethene class. The compound has alkoxy group and aryl group on the heteroaryl group.
An image forming medium includes a paper substrate and an imaging layer coated on or impregnated into a paper substrate, where the imaging layer is formed of an imaging composition that includes an alkoxy substituted diarylethene photochromic material dissolved or dispersed in a solvent or polymeric binder, and where the imaging composition exhibits a reversible transition between a colorless and a colored state.
A photochromic material having a ring opening quantum yield of 10−3 or lower which does not fade under ambient light is provided. The material comprises a compound belonging to the diheteroarylethene class. The compound has alkoxy group and aryl group on the heteroaryl group.
[EN] TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN<br/>[FR] DÉGRADATION DE PROTÉINE CIBLÉE À L'AIDE DE COMPOSÉS BIFONCTIONNELS QUI SE LIENT À LA LIGASE D'UBIQUITINE ET À LA PROTÉINE MCL-1 CIBLE
申请人:CAPTOR THERAPEUTICS S A
公开号:WO2022253713A1
公开(公告)日:2022-12-08
A compound of formula (I); [MCL-1 ligand moiety] - [linker] - [ligase ligand moiety] (I); or a salt, solvate, hydrate, isomer or prodrug thereof, wherein [MCL-1 ligand moiety] is a compound of Formula (A), Formula (B) or Formula (C), and its use in the treatment of cancer.